Yue Wu
State Key Laboratory Of Natural Medicines, Jiangsu Key Laboratory Of Drug Design And Optimization
Nanjing, 211198, China
Nanjing, 211198, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Lysine-Targeted Covalent Inhibitors: Emerging Warheads and Expanding Applications in Medicinal Chemistry.
Journal: Journal of medicinal chemistry
Published: May 27, 2026
A Near-Infrared Photoactivatable, Brain-Penetrant Prodrug of the Prolyl Hydroxylase Inhibitor Vadadustat for Neuroprotection in Ischemic Stroke.
Journal: Journal of medicinal chemistry
Published: May 02, 2026
Rapid Identification of Multiple Types of Adulterated Ophiocordyceps sinensis by SEM-EDS Based on Micromorphology and Elemental Analysis.
Journal: Microscopy research and technique
Published: March 27, 2026
Discovery of 3-(Arylamido)pyrazolopyridine HIF-2α Agonists and a Codrug Strategy with Prolyl Hydroxylase Inhibition for Synergistic Treatment of Renal Anemia.
Journal: Journal of medicinal chemistry
Published: November 21, 2025
Group 3 Innate Lymphoid Cells (ILC3s): A Promising Immune Cell Group as Therapeutic Targets for Sjögren's Syndrome.
Journal: Current pharmaceutical design
Published: August 26, 2025
Discovery of ZG-2305, an Orally Bioavailable Factor Inhibiting HIF Inhibitor for the Treatment of Obesity and Fatty Liver Disease.
Journal: Journal of medicinal chemistry
Published: October 21, 2024
A comprehensive review on wedelolactone: natural sources, total synthesis, and pharmacological activities.
Journal: Chinese journal of natural medicines
Published: July 08, 2024
Uric Acid: A Biomarker and Pathogenic Factor of Affective Disorders and Neurodegenerative Diseases.
Journal: Current pharmaceutical design
Published: June 25, 2024
A Small-Molecule Inhibitor of Factor Inhibiting HIF Binding to a Tyrosine-Flip Pocket for the Treatment of Obesity.
Journal: Angewandte Chemie (International ed. in English)
Published: June 03, 2024
Preferred Conformation-Guided Discovery of Potent and Orally Active HIF Prolyl Hydroxylase 2 Inhibitors for the Treatment of Anemia.
Journal: Journal of medicinal chemistry
Published: June 27, 2023
In Situ Inhibitor Synthesis and Screening by Fluorescence Polarization: An Efficient Approach for Accelerating Drug Discovery.
Journal: Angewandte Chemie (International ed. in English)
Published: August 04, 2022
In Situ Inhibitor Synthesis and Screening by Fluorescence Polarization: An Efficient Approach for Accelerating Drug Discovery.
Journal: Angewandte Chemie (Weinheim an der Bergstrasse, Germany)
Published: August 04, 2022
Last Updated: 09/26/2026